CARBAMAZEPINE USE IN AGGRESSIVE BEHAVIOU
โ
COLM COONEY; ANN MORTIMER; ANDREW SMITH; KATE NEWTON; MARGO WRIGLEY
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 354 KB
๐ 2 views
In a randomized placebo crossover controlled study, six patients meeting DSM-111-R criteria for Alzheimer's disease and exhibiting significantly aggressive behaviour were administered carbamazepine (in doses up to 600 mg daily) and placebo, with each treatment period lasting 8 weeks. Levels of aggre